Nature’s Sunshine Products (NASDAQ:NATR) EVP Sells $37,893.00 in Stock
by Kim Johansen · The Markets DailyNature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) EVP Bryant Yates sold 1,700 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $22.29, for a total transaction of $37,893.00. Following the transaction, the executive vice president directly owned 98,604 shares of the company’s stock, valued at $2,197,883.16. This trade represents a 1.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Nature’s Sunshine Products Trading Up 0.8%
Shares of NATR stock opened at $22.54 on Friday. The stock has a market capitalization of $394.45 million, a price-to-earnings ratio of 27.83 and a beta of 0.98. Nature’s Sunshine Products, Inc. has a 12-month low of $11.01 and a 12-month high of $24.12. The stock’s 50-day moving average price is $18.25 and its 200-day moving average price is $16.53.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. The company had revenue of $88.99 million during the quarter, compared to analyst estimates of $119.39 million. Nature’s Sunshine Products had a return on equity of 10.86% and a net margin of 3.18%.
Wall Street Analysts Forecast Growth
NATR has been the topic of several research reports. DA Davidson boosted their price target on shares of Nature’s Sunshine Products from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Nature’s Sunshine Products in a research report on Monday. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Nature’s Sunshine Products has an average rating of “Moderate Buy” and an average target price of $22.50.
Check Out Our Latest Analysis on NATR
Institutional Trading of Nature’s Sunshine Products
Several hedge funds and other institutional investors have recently bought and sold shares of NATR. Connor Clark & Lunn Investment Management Ltd. lifted its position in Nature’s Sunshine Products by 80.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 38,602 shares of the company’s stock worth $484,000 after buying an additional 17,168 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Nature’s Sunshine Products in the first quarter valued at $437,000. Russell Investments Group Ltd. lifted its holdings in shares of Nature’s Sunshine Products by 351.2% in the 1st quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company’s stock worth $156,000 after acquiring an additional 9,650 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Nature’s Sunshine Products during the 1st quarter worth about $174,000. Finally, Acadian Asset Management LLC boosted its stake in shares of Nature’s Sunshine Products by 1.6% during the 1st quarter. Acadian Asset Management LLC now owns 473,533 shares of the company’s stock worth $5,933,000 after purchasing an additional 7,281 shares during the period. Hedge funds and other institutional investors own 79.40% of the company’s stock.
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Stories
- Five stocks we like better than Nature’s Sunshine Products
- How to Short Nasdaq: An Easy-to-Follow Guide
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- How to Read Stock Charts for Beginners
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Short Selling – The Pros and Cons
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast